Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Mesoblast Limited MESO rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.

Mesoblast shares jumped 13.4% to $2.4399 on Monday.

Here are some other stocks moving in today's mid-day session.


  • Kidpik Corp. PIK gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split.
  • TC Biopharm (Holdings) Plc TCBP shares surged 149% to $2.6450.
  • TRxADE HEALTH, Inc. MEDS gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share.
  • Fangdd Network Group Ltd. DUO shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector.
  • GDS Holdings Limited GDS shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business.
  • Solidion Technology Inc. STI rose 23.3% to $0.9620.
  • Kingsoft Cloud Holdings Limited KC shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024.
  • EHang Holdings Limited EH gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024.
  • Bally's Corporation BALY gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally's proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company.
  • Rail Vision Ltd. RVSN climbed 21.2% to $3.43. Rail Vision received an order from a Class 1 US railroad company for its AI-based safety system.
  • Marpai, Inc. MRAI gained 18.7% to $2.0899.
  • bioAffinity Technologies, Inc. BIAF climbed 18.3% to $1.81.
  • Lixiang Education Holding Co., Ltd. LXEH gained 15.6% to $4.8797.
  • Lexicon Pharmaceuticals, Inc. LXRX jumped 13.4% to $2.4650 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
  • NWTN Inc. NWTN gained 13.4% to $4.8082.
  • Pulse Biosciences, Inc. PLSE rose 12.7% to $10.86. Pulse Biosciences announced FDA 510(k) clearance for Cellfx NSPFA Percutaneous Electrode System.
  • Bilibili Inc. BILI gained 12.7% to $12.55 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $10 to $11. The stock is also gaining amid overall China strength following the annual National People's Congress event.
  • Graphite Bio, Inc. GRPH climbed 11.7% to $3.5080. Graphite Bio declared a special dividend in connection with proposed merger with Lenz Therapeutics.
  • STAAR Surgical Company STAA jumped 10% to $39.45 after Stifel upgraded the stock from Hold to Buy and raised its price target from $30 to $50.
  • VNET Group, Inc. VNET rose 9.8% to $1.68.
  • Moderna, Inc. MRNA gained 9.2% to $112.51.
  • Ituran Location and Control Ltd. ITRN climbed 7.8% to $28.42.
  • NuScale Power CorporationSMR gained 7% to $5.87. NuScale Power is expected to release fourth quarter results on March 14, 2024.
  • MicroStrategy Incorporated MSTR gained 4.7% to $1,492.07 amid continued strength in Bitcoin.


  • Jeffs' Brands Ltd JFBR fell 45.2% to $0.8650.
  • Eltek Ltd. ELTK shares fell 20.9% to $11.00 after the company announced downbeat quarterly earnings.
  • CERo Therapeutics Holdings, Inc. CERO declined 22% to $3.0822 after jumping 28% on Friday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.
  • The Real Good Food Company, Inc. RGF fell 19.7% to $0.5536.
  • Ventyx Biosciences, Inc. VTYX dipped 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
  • Lytus Technologies Holdings PTV. Ltd. LYT fell 15.3% to $6.78 after declining 8% on Friday. Lytus Technologies, last week, announced the launch of Lytus Cloud.
  • Next.e.GO N.V. EGOX declined 15.3% to $0.0727.
  • MoneyLion Inc. ML fell 15% to $63.36.
  • Semilux International Ltd. SELX fell 14.8% to $1.4403 after jumping 69% on Friday.
  • Lytus Technologies Holdings PTV. Ltd. LYT fell 14.6% to $6.83.
  • Barnes & Noble Education, Inc. BNED dipped 13.8% to $0.7832. Barnes & Noble Education recently rescheduled its third quarter fiscal year 2024 earnings release.
  • Psyence Biomedical Ltd. PBM fell 13.4% to $1.8272 after jumping 66% on Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.
  • Immuron Limited IMRN shares tumbled 12.5% to $3.3252 after dipping 16% on Friday.
  • Genie Energy Ltd. GNE fell 12% to $16.67 following fourth-quarter results.
  • Nanobiotix S.A. NBTX dipped 9.8% to $6.35.
  • Avenue Therapeutics, Inc. ATXI fell 8.9% to $0.1749 after surging 10% on Friday.
  • Super Micro Computer, Inc. SMCI dipped 8.8% to $1,039.60.
  • MannKind Corporation MNKD declined 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.
  • Poseida Therapeutics, Inc. PSTX fell 8.1% to $3.74.


Now Read This: Wall Street's Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 3% Dividend Yields

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!